Standard
Letter : the clinical course of Crohn’s disease—the Sicilian experience. Authors’ reply. / Burisch, Johan; Langholz, Ebbe; Munkholm, Pia.
I:
Alimentary Pharmacology and Therapeutics, Bind 55, Nr. 9, 2022, s. 1239-1240.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Burisch, J
, Langholz, E & Munkholm, P 2022, '
Letter: the clinical course of Crohn’s disease—the Sicilian experience. Authors’ reply',
Alimentary Pharmacology and Therapeutics, bind 55, nr. 9, s. 1239-1240.
https://doi.org/10.1111/apt.16898APA
Burisch, J.
, Langholz, E., & Munkholm, P. (2022).
Letter: the clinical course of Crohn’s disease—the Sicilian experience. Authors’ reply.
Alimentary Pharmacology and Therapeutics,
55(9), 1239-1240.
https://doi.org/10.1111/apt.16898Vancouver
Burisch J
, Langholz E, Munkholm P.
Letter: the clinical course of Crohn’s disease—the Sicilian experience. Authors’ reply.
Alimentary Pharmacology and Therapeutics. 2022;55(9):1239-1240.
https://doi.org/10.1111/apt.16898Author
Burisch, Johan ; Langholz, Ebbe ; Munkholm, Pia. / Letter : the clinical course of Crohn’s disease—the Sicilian experience. Authors’ reply. I: Alimentary Pharmacology and Therapeutics. 2022 ; Bind 55, Nr. 9. s. 1239-1240.
Bibtex
@article{33b80553e9e64f8a9a518e5c873c424a,
title = "Letter: the clinical course of Crohn{\textquoteright}s disease—the Sicilian experience. Authors{\textquoteright} reply",
author = "Johan Burisch and Ebbe Langholz and Pia Munkholm",
note = "Funding Information: The authors' declarations of personal and financial interests remain unchanged from those stated in the original article.1",
year = "2022",
doi = "10.1111/apt.16898",
language = "English",
volume = "55",
pages = "1239--1240",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "9",
}
RIS
TY - JOUR
T1 - Letter
T2 - the clinical course of Crohn’s disease—the Sicilian experience. Authors’ reply
AU - Burisch, Johan
AU - Langholz, Ebbe
AU - Munkholm, Pia
N1 - Funding Information:
The authors' declarations of personal and financial interests remain unchanged from those stated in the original article.1
PY - 2022
Y1 - 2022
U2 - 10.1111/apt.16898
DO - 10.1111/apt.16898
M3 - Comment/debate
C2 - 35429028
AN - SCOPUS:85128217167
VL - 55
SP - 1239
EP - 1240
JO - Alimentary Pharmacology and Therapeutics, Supplement
JF - Alimentary Pharmacology and Therapeutics, Supplement
SN - 0953-0673
IS - 9
ER -
